Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFidelity Regulatory News (FSV)

Share Price Information for Fidelity (FSV)

Share Price is delayed by 15 minutes
Get Live Data
427.50    -0.50 (-0.12%)
Bid:
426.50
Ask:
428.00
Spread: 1.50 (0.352%)
Market Cap: £1.39b
FSV Live PriceLast checked at - London Stock Exchange

Intraday Fidelity Share Chart

Issue of Equity

22 Mar 2022 16:42

Fidelity Special Values Plc - Issue of Equity

Fidelity Special Values Plc - Issue of Equity

PR Newswire

London, March 22

Fidelity Special Values PLC

Issue of Ordinary Shares

On 22 March 2022, Fidelity Special Values PLC (the “Company”) issued from its block listing facility of 14 December 2020, a total of 185,000 new shares, 50,000 at a price of 293.60 pence per share and 135,000 at a price of 294.00 pence per share. These shares rank pari passu with the existing Ordinary shares in issue.

Following this issue, there are 1,095,000 Ordinary shares available under the Company’s block listing facility of 14 December 2020. In addition, the Company also has 30,000,000 ordinary shares under its block listing facility of 7 February 2022.

As a result of this issue, the total number of Ordinary shares in issue now stands at 323,918,920. There are no shares held in Treasury, therefore the total number of Ordinary shares with voting rights in the Company is 323,918,920.

The above figure of Ordinary shares with voting rights (323,918,920) may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.

Smita Amin

For and on behalf of FIL Investments International

Company Secretary

01737 836347

22 March 2022

Date   Source Headline
1st Sep 20254:20 pmPRNTotal Voting Rights
1st Sep 20257:47 amRNSNet Asset Value(s)
29th Aug 20259:49 amRNSNet Asset Value(s)
28th Aug 20257:45 amRNSNet Asset Value(s)
27th Aug 20257:43 amRNSNet Asset Value(s)
26th Aug 202512:12 pmPRNMonthly Factsheet
26th Aug 20257:32 amRNSNet Asset Value(s)
22nd Aug 20257:44 amRNSNet Asset Value(s)
21st Aug 20257:41 amRNSNet Asset Value(s)
20th Aug 20257:40 amRNSNet Asset Value(s)
19th Aug 20257:52 amRNSNet Asset Value(s)
18th Aug 20257:37 amRNSNet Asset Value(s)
15th Aug 20257:50 amRNSNet Asset Value(s)
14th Aug 20257:48 amRNSNet Asset Value(s)
13th Aug 20257:52 amRNSNet Asset Value(s)
12th Aug 20257:46 amRNSNet Asset Value(s)
11th Aug 20257:37 amRNSNet Asset Value(s)
8th Aug 20257:47 amRNSNet Asset Value(s)
7th Aug 20251:38 pmPRNBlocklisting - Interim Review
7th Aug 20257:38 amRNSNet Asset Value(s)
6th Aug 20257:35 amRNSNet Asset Value(s)
5th Aug 20258:01 amRNSNet Asset Value(s)
4th Aug 20257:57 amRNSNet Asset Value(s)
1st Aug 20254:50 pmPRNTotal Voting Rights
1st Aug 20257:56 amRNSNet Asset Value(s)
31st Jul 20257:49 amRNSNet Asset Value(s)
30th Jul 20257:35 amRNSNet Asset Value(s)
29th Jul 20257:54 amRNSNet Asset Value(s)
28th Jul 20257:45 amRNSNet Asset Value(s)
25th Jul 20257:52 amRNSNet Asset Value(s)
24th Jul 20257:43 amRNSNet Asset Value(s)
23rd Jul 20257:47 amRNSNet Asset Value(s)
22nd Jul 202512:30 pmPRNMonthly Factsheet
22nd Jul 20257:52 amRNSNet Asset Value(s)
21st Jul 20257:39 amRNSNet Asset Value(s)
18th Jul 20257:49 amRNSNet Asset Value(s)
17th Jul 20257:43 amRNSNet Asset Value(s)
16th Jul 20257:44 amRNSNet Asset Value(s)
15th Jul 20257:56 amRNSNet Asset Value(s)
14th Jul 20257:47 amRNSNet Asset Value(s)
11th Jul 20255:18 pmPRNDirector/PDMR Shareholding
11th Jul 20257:27 amRNSNet Asset Value(s)
10th Jul 20257:53 amRNSNet Asset Value(s)
9th Jul 20257:44 amRNSNet Asset Value(s)
8th Jul 20257:48 amRNSNet Asset Value(s)
7th Jul 20257:42 amRNSNet Asset Value(s)
4th Jul 20257:45 amRNSNet Asset Value(s)
3rd Jul 20257:54 amRNSNet Asset Value(s)
2nd Jul 20257:57 amRNSNet Asset Value(s)
1st Jul 20253:45 pmPRNTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.